Section Clinical Tropical Medicine, Department for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Department of Infectious Disease Epidemiology, London School of Tropical Medicine and Hygiene, London, United Kingdom.
PLoS Negl Trop Dis. 2020 Mar 4;14(3):e0008076. doi: 10.1371/journal.pntd.0008076. eCollection 2020 Mar.
Severe dengue was perceived as one clinical disease entity until the WHO 2009 classification stratified it into severe vascular leakage, severe bleeding, and severe organ dysfunction. The objectives of this study were to investigate the potential use of severe dengue categories as endpoints for intervention research. 271 patients with severe dengue among 1734 confirmed dengue patients were followed prospectively in this hospital-based observational study in Latin America and Asia. We compared the distribution of severe dengue categories according to gender and age (below/above 15y), and determined the relative frequency and the overlap of severe dengue categories in the same patients. In a next step, we extended the analysis to candidate moderate severity categories, based on recently suggested definitions which were adapted for our purposes. Severe vascular leakage occurred in 244 (90%), severe bleeding in 39 (14%), and severe organ dysfunction in 28 (10%) of 271 severe dengue patients. A higher frequency of severe leakage was seen in children or adolescents (<15y) compared to adults. More than 80% of the severe leakage cases, and 30-50% of the cases with severe bleeding or severe organ dysfunction, were defined as severe on the basis of that feature alone. In 136 out of 213 patients with severe leakage alone, neither moderate bleeding manifestation nor hepatic involvement was recorded. On the other hand, moderate leakage manifestations were detected in 4 out of 12 cases that were classified as severe based on bleeding alone. A major proportion of severe dengue patients exhibited clinical manifestations of severe vascular leakage only, which may constitute a useful endpoint for intervention research or pathophysiology studies. Severe bleeding and severe organ manifestation were recorded less frequently and exhibited a higher degree of overlap with severe leakage. Severe bleeding without leakage may be associated with individual predisposition or the presence of comorbidities. More detailed assessments are needed to explore this hypothesis. Candidate moderate disease endpoints were investigated and need to be further validated.
重症登革热曾被视为一种临床疾病实体,直到世卫组织 2009 年的分类将其分为严重血管渗漏、严重出血和严重器官功能障碍。本研究的目的是探讨将重症登革热类别用作干预研究终点的潜在用途。在这项拉丁美洲和亚洲的医院观察性研究中,对 1734 例确诊登革热患者中的 271 例重症登革热患者进行了前瞻性随访。我们比较了根据性别和年龄(<15 岁/>15 岁)分布的重症登革热类别,并确定了同一患者中重症登革热类别的相对频率和重叠。在下一步中,我们根据最近提出的定义,扩展了对候选中度严重类别的分析,这些定义是为我们的目的而改编的。在 271 例重症登革热患者中,有 244 例(90%)发生严重血管渗漏,39 例(14%)发生严重出血,28 例(10%)发生严重器官功能障碍。与成年人相比,儿童或青少年(<15 岁)发生严重渗漏的频率更高。超过 80%的严重渗漏病例,以及 30-50%的严重出血或严重器官功能障碍病例,仅根据该特征就被定义为严重。在 213 例单纯严重渗漏的患者中,有 136 例未记录到中度出血表现或肝受累。另一方面,在 12 例仅因出血而被归类为严重的病例中,检测到中度渗漏表现。很大一部分重症登革热患者仅表现出严重血管渗漏的临床表现,这可能构成干预研究或病理生理学研究的有用终点。严重出血和严重器官表现记录较少,与严重渗漏表现有更高程度的重叠。无渗漏的严重出血可能与个体易感性或合并症有关。需要更详细的评估来探讨这一假设。候选中度疾病终点进行了调查,需要进一步验证。